The R&D 15: How pharma's top companies spent, won and lost on drug research
Talking over pharma pipelines with a major drugmaker's development chief, he noted that if you looked at the biggest 50 drugs by revenue, the final one on the list brought in about $4 billion last ...
read at Endpoints ↗Neutral
April 30, 2026 07:15 AM EDT BioregnumSpecialPharma The R&D 15: The stakes needed to play in the world's biggest drug research groups require very deep pockets John Carroll Editor & Founder Talking over pharma pipelines with a major drugmaker’s development chief, he noted that if you looked at the biggest 50 drugs by revenue, the final … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that